Schering-Plough Indonesia expects 20% profit rise<\/p>\n
JAKARTA (JP): The manufacturer of pharmaceutical products, PT
\nSchering-Plough Indonesia, expects its profits to rise 20 percent
\nthis year, company spokesman Tjiptono Darmadji said yesterday.<\/p>\n
Tjiptono said the profit rise would result from a price rise
\nof between 8 percent and 9 percent and increased sales.<\/p>\n
He did not say how much he expected sales to rise.<\/p>\n
The company reported a 33 percent profit growth to Rp 7.3
\nbillion for 1995.<\/p>\n
\"Overall, our company is in good financial shape, meaning that
\nour performance has improved steadily over the years,\" he said.<\/p>\n
Schering-Plough Indonesia, a joint venture involving Schering
\nCorporation of the United States, is one of nine chemical
\ncompanies listed on the Jakarta Stock Exchange.<\/p>\n
The company's annual earning per share increased to Rp 2,093
\n(87 U.S. cents) last year from Rp 2,040 in 1995.<\/p>\n
Tjiptono said the company's sales had continuously increased
\nfrom Rp 25.18 billion in 1993 to Rp 30.16 billion in 1994 and Rp
\n39.74 billion in 1995.<\/p>\n
Special exports to Russia caused an 112 percent increase in
\nthe company's export earnings to Rp 8.43 billion in 1995 from Rp
\n3.97 billion in 1994.<\/p>\n
Between January and November last year, it made Rp 3.9 billion
\nin export earnings, around 10 percent of its total sales of Rp
\n35.23 billion.<\/p>\n
The company plans to launch new products and new versions of
\nexisting products in new markets this year.<\/p>\n
Tjiptono said the launch of a new version of the company's
\nClaritine, a widely-used non-sedative antihistamine, in the next
\nfew months was expected to push up this year's sales.<\/p>\n
Tjiptono said he was optimistic that sales of Claritine would
\nincrease following a recent announcement by the U.S. Food and
\nDrugs Administration office to withdraw Seldane and Seldane D,
\ntwo brands of antihistamines which are said to cause serious
\nside-effects.<\/p>\n
Other products manufactured by the company include hepatitis
\nmedication, injectable antibiotics and dermatology products. (02)<\/p>",
"url": "https:\/\/jawawa.id\/newsitem\/schering-plough-indonesia-expects-20-profit-rise-1447893297",
"image": ""
},
"sponsor": "Okusi Associates",
"sponsor_url": "https:\/\/okusiassociates.com"
}